Brief: Phio Pharmaceuticals Appoints Lisa Carson As Principal Financial Officer - SEC Filing
12/06/2025 12:58
June 12 (Reuters) - Phio Pharmaceuticals Corp PHIO.O: PHIO PHARMACEUTICALS CORP - ON JUNE 6, APPOINTS LISA CARSON AS PRINCIPAL FINANCIAL OFFICER - SEC FILING Source text: [ID:n0001683168-25-004421] Further company coverage: PHIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing